·
1 minute read
The Pediatric Otolaryngology Workforce: Past, Present, and Future
Sunday, October 12 | 8:00 – 9:00 am | 500 Ballroom
The pediatric otolaryngology workforce has undergone a remarkable transformation over the past five decades. As demand for specialized care continues to grow, how will the field ensure that every child who needs expert treatment can access it? In this year's Cotton-Fitton Endowed Lecture in Pediatric Otolaryngology, Craig S. Derkay, MD, explores this critical question and charts a course for meeting the future ENT care needs of children.
Dr. Derkay will trace the history of the pediatric otolaryngology workforce from its beginnings in the mid-1970s with a dozen North American visionaries to a present-day workforce of more than a 1,000 doctors of medicine, doctors of osteopathic medicine, and advanced practice providers. He will address the current and future challenges to the subspecialty in maintaining access for families while assuring the public of a high standard of care.
Dr. Derkay is the Fine Endowed Professor of Pediatric Otolaryngology at Eastern Virginia Medical School, vice-chairman of the Otolaryngology Department, and professor in the Department of Pediatrics. He has also served as chief of the Department of Surgery and the Division Chief of Pediatric Otolaryngology at the Children’s Hospital of the King’s Daughters.
Dr. Derkay graduated from the University of Virginia and the Medical College of Virginia (MCV, now known as the Virginia Commonwealth University School of Medicine). He completed his general surgical internship at MCV and his otolaryngology residency at the University of Pittsburgh. He went on to a fellowship in pediatric otolaryngology at Children’s National Hospital in Washington, DC.
Dr. Derkay has chaired the AAO-HNS Pediatric Otolaryngology Committee and was the AAO-HNS representative to the American Medical Association. He has authored more than 160 peer-reviewed publications and 30 book chapters. He has been a visiting professor at more than three dozen institutions in the United States and abroad. He has served on advisory committees for the National Institutes of Health, the Centers for Disease Control, and the Food and Drug Administration.
